Fundz

Green Bioactives Completes £2.6M Seed Financing To Advance Its Sustainable Plant Products Biomanufacturing Platform

PRIVATEDec 13, 2022

Amount Raised

£2.6 Million

Round Type

Seed

EdinburghBiotechnologyAgriculture and Farming

Investors

Agtech FundRegenerate Ventures

Description

Green Bioactives Ltd ('GBL'), a world-leader in the discovery, development and sustainable production of high-value natural products derived from plant cell cultures, announces that it has successfully completed a £2.6 million seed financing round. The funding round was led by Eos Advisory LLP and included investments from London-based Regenerate Ventures' Agtech Fund, London and Singapore co-headquartered Milltrust International Group, and Scottish Enterprise, which also provided the company with advisory support.

Quick answer

Green Bioactives raised £2.6 Million in a Seed round, dated December 13, 2022. Investors: Agtech Fund and Regenerate Ventures. Green Bioactives is based in Edinburgh, Scotland, United Kingdom.

How much did Green Bioactives raise?
Green Bioactives raised £2.6 Million in a Seed round on December 13, 2022.
Who invested in Green Bioactives?
Agtech Fund and Regenerate Ventures are named as investors in this round.
What does Green Bioactives do?
Green Bioactives ("GBL") is a world leader in the commercial utilisation of plant vascular stem cells, which has allowed it to create a reliable and economically attractive platform for the sustainable biomanufacturing..
Where is Green Bioactives based and how big is it?
Green Bioactives is based in Edinburgh, Scotland, United Kingdom.

Source: Fundz verified event record.

Who else raised in Agriculture and Farming and Biotechnology around the same time

Companies in the same sectors as Green Bioactives that raised within 45 days of this round, from Fundz verified event records.

  • UPP raised $653K (Seed) on January 26, 2023.
  • PBS Biotech raised $22M (Funding Round) on January 9, 2023.
  • Basecamp Research raised $20M (Funding Round) on December 14, 2022.
  • Vytelle raised an undisclosed amount (Series A) on November 30, 2022.
  • Symbiome raised an undisclosed amount on October 31, 2022.
  • Grey Wolf Therapeutics raised $49M (Funding Round) on January 27, 2023.

Who to call at Green Bioactives, and when

A new round usually means Green Bioactives is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Green Bioactives raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Green Bioactives, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Green Bioactives. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Green Bioactives

Location

Edinburgh, Scotland, United Kingdom

About

Green Bioactives ("GBL") is a world leader in the commercial utilisation of plant vascular stem cells, which has allowed it to create a reliable and economically attractive platform for the sustainable biomanufacturing of plant biomolecules for commercial applications in the cosmetics, pharma, food and agricultural industries. GBL's platform provides much improved and sustainable access to the huge, diverse, and valuable library of bioactives generated by the world's plant population. GBL is working with several world leading partners to produce high value bioactives that cannot be produced sustainably or economically using other approaches. The company's capabilities span initial isolation of the bioactive producing plant cells through to the supply of the final purified product. GBL's knowledge of plant vascular stem cells also provides the opportunity for the company to develop novel approaches that address the global need for sustainable, more efficient food production. GBL was founded in 2020 and is currently based at the Roslin Innovation Centre, Edinburgh, Scotland, UK. For more information visit: www.green-bioactives.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Green Bioactives raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Green Bioactives's next move

See what Strategic adds

Green Bioactives raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.